- Home
- TRS vs HROW Comparison
TRS vs HROW Comparison
Compare TRS & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- HROW
- Stock Information
- Founded
- TRS 1986
- HROW 1998
- Country
- TRS United States
- HROW United States
- Employees
- TRS N/A
- HROW N/A
- Industry
- TRS Industrial Specialties
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- TRS Industrials
- HROW Health Care
- Exchange
- TRS Nasdaq
- HROW Nasdaq
- Market Cap
- TRS 1.5B
- HROW 1.4B
- IPO Year
- TRS 2007
- HROW N/A
- Fundamental
- Price
- TRS $37.36
- HROW $39.74
- Analyst Decision
- TRS Strong Buy
- HROW Strong Buy
- Analyst Count
- TRS 2
- HROW 7
- Target Price
- TRS $45.00
- HROW $68.50
- AVG Volume (30 Days)
- TRS 460.8K
- HROW 889.7K
- Earning Date
- TRS 10-28-2025
- HROW 11-12-2025
- Dividend Yield
- TRS 0.43%
- HROW N/A
- EPS Growth
- TRS N/A
- HROW N/A
- EPS
- TRS 0.91
- HROW N/A
- Revenue
- TRS $973,840,000.00
- HROW $227,661,000.00
- Revenue This Year
- TRS $11.03
- HROW $43.92
- Revenue Next Year
- TRS $6.13
- HROW $41.32
- P/E Ratio
- TRS $41.08
- HROW N/A
- Revenue Growth
- TRS 6.72
- HROW 47.69
- 52 Week Low
- TRS $19.33
- HROW $20.85
- 52 Week High
- TRS $40.34
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- TRS 44.34
- HROW 45.21
- Support Level
- TRS $36.73
- HROW $40.79
- Resistance Level
- TRS $38.07
- HROW $48.79
- Average True Range (ATR)
- TRS 0.86
- HROW 2.41
- MACD
- TRS -0.38
- HROW -0.87
- Stochastic Oscillator
- TRS 14.13
- HROW 11.18
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.